1,721,448 research outputs found
MS Study Group of the Italian Neurological Society.Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up.Neurology. 2014 Oct 14;83(16):1432-8. doi: 10.1212/WNL.0000000000000885. Epub 2014 Sep 12.
No full textAdvances in the management of multiple sclerosis spasticity: Experiences from recent studies and everyday clinical practice
No full textTeriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group.Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.Mult Scler. 2013 Sep;19(10):1310-9. doi: 10.1177/1352458513475723. Epub 2013 Feb 27.
No full textItalian MS Study Group. Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.Mult Scler. 2013 Jul;19(8):1106-12. doi: 10.1177/1352458512471878. Epub 2013 Feb 11.
No full textMS Study Group of the Italian Neurological Society.Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.
No full textEAP Investigators.Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.BMC Neurol. 2014 Apr 1;14:65. doi: 10.1186/1471-2377-14-65.
No full text
MS Study Group of the Italian Neurological Society.Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.
No full textMS Study Group of the Italian Neurological Society. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.
No full textDEFINE Study Investigators.Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.N Engl J Med. 2012 Sep 20;367(12):1098-107. Erratum in: N Engl J Med. 2012 Dec 13;367(24):2362.
No full text- …
